Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
FTC sues pharmaceutical middlemen, claiming practices inflated insulin cost
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming unfair practices inflated the cost of insulin.
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
Express Scripts sues FTC over report blasting pharmacy middlemen
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
Express Scripts sues FTC over report blaming pharmacy middlemen for high drug costs
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” Express Scripts claims in the lawsuit that the report “is seventy-four pages of unsupported innuendo” leveled against it and other PBMs.
FTC Sues Prescription Drug Middlemen Including CVS for Artificially Inflating Insulin Drug Prices
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx (a CVS company), Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Modern Healthcare
3d
Express Scripts sues FTC over 'flawed and biased' PBM report
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the ...
Fierce Healthcare
3d
Express Scripts files suit against FTC, demands retraction of report on PBM industry
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on ...
20h
on MSN
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
TN abortion law blocked
Sesame Place suit verdict
Jurors begin deliberations
Boeing defense chief exits
Drug price challenge revived
SC 1st execution in 13 years
$230 million crypto theft
Pandas leaving for China
Russia threatens retaliation
Body found in SUV
FDA approves flu vaccine
WI high court to decide
Feds subpoena Schaeffer
Hand count approved in GA
In-person voting begins
144K+ Mavericks recalled
Bill to boost security OK'd
Top Hezbollah leader killed?
House repeals emission rules
Sues pharmacy middlemen
Baby powder recalled
Disney to stop using Slack
Stein's ballot bid rejected
$3B for battery projects
MS sheriff's office probe
Recalling 449K+ vehicles
1st rabies outbreak in seals
Hiker injured in bear attack
Feedback